Why is Frequency Therapeutics, Inc. ?
1
Positive results in Jun 25
- NET SALES(HY) Higher at USD 4.01 MM
- NET PROFIT(HY) Higher at USD -49.16 MM
- RAW MATERIAL COST(Y) Fallen by -1,781% (YoY)
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -19.30%, its profits have fallen by -8.1%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 19.11% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -19.30% returns
How much should you hold?
- Overall Portfolio exposure to Frequency Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Frequency Therapeutics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Frequency Therapeutics, Inc.
-85.67%
-0.22
137.04%
S&P 500
13.22%
0.96
19.87%
Quality key factors
Factor
Value
Sales Growth (5y)
-32.47%
EBIT Growth (5y)
-224.81%
EBIT to Interest (avg)
-76.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.81
Sales to Capital Employed (avg)
0.03
Tax Ratio
0.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.98
EV to EBIT
-0.25
EV to EBITDA
-0.26
EV to Capital Employed
0.91
EV to Sales
4.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-362.89%
ROE (Latest)
-62.91%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Movement
12What is working for the Company
NET SALES(HY)
Higher at USD 4.01 MM
NET PROFIT(HY)
Higher at USD -49.16 MM
RAW MATERIAL COST(Y)
Fallen by -1,781% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 11.54%
-4What is not working for the Company
OPERATING PROFIT(Q)
Lowest at USD -26 MM
PRE-TAX PROFIT(Q)
Lowest at USD -25.77 MM
NET PROFIT(Q)
Lowest at USD -25.77 MM
EPS(Q)
Lowest at USD -2.74
Here's what is working for Frequency Therapeutics, Inc.
Net Sales
Higher at USD 4.01 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Debtors Turnover Ratio
Highest at 11.54%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -1,781% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Frequency Therapeutics, Inc.
Operating Profit
Lowest at USD -26 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -25.77 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -25.77 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -2.74
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)






